National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in India

Aug 21, 2023 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Ministry of Chemicals and Fertilizers (MoCF) on August 18, 2023, issued the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in India to achieve Atmanirbharata in Pharma- MedTech sector through measures to accelerate R&D and innovation.

The main objective of the scheme is as follows:

• To enable rapid drug discovery and development and innovation in medical devices by streamlining of regulatory processes; 

• To incentivize private sector investment in research and explore various funding mechanisms – Budgetary support, Venture capital, CSR funding, etc. and fiscal incentives to support innovation; 

• To strengthen the R&D ecosystem through increased collaboration between Industry and Academia; 

• To enable coordination among the existing policies and programs of various departments/ agencies/institutes in order to develop mechanisms to dovetail research as per the requirement of the sector; and 

• To facilitate the rapid development and availability of innovative drugs and medical devices in India.

Kindly find the detailed policy in the document. 

[Notification No. 50020/5/2020-NIPER (R&D)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT